Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans
about
Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infectionHLA class II allele polymorphism in an outbreak of chikungunya fever in Middle Andaman, IndiaAssociations of human leucocyte antigen class II-DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family-based study.Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patientsMolecular mechanisms of liver fibrosis in HIV/HCV coinfectionHepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremiaHepatitis C virus infection in the human immunodeficiency virus infected patient.Host genetic determinants of spontaneous hepatitis C clearance.Coinfection with HIV-1 and HCV--a one-two punch.Role of host genetic factors in the outcome of hepatitis C virus infection.Donor Risk Index for African American liver transplant recipients with hepatitis C virus.Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children.Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus.Host genetics in immune-mediated hepatitis C virus clearance.Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections.Methodologies for the Analysis of HCV-Specific CD4(+) T CellsDifferent DRB1*03:01-DQB1*02:01 haplotypes confer different risk for celiac disease.T-cell epitopes predicted from the Nucleocapsid protein of Sin Nombre virus restricted to 30 HLA alleles common to the North American population.Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.The host HLA-A*02 allele is associated with the response to pegylated interferon and ribavirin in patients with chronic hepatitis C virus infection.Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C.IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors.Spontaneous Elimination of Hepatitis C Virus Infection.The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response.Protective effect of HLA-DRB1 11 and predisposition of HLA-C 04 in the development of severe liver damage in Brazilian patients with chronic hepatitis C virus infection.Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population.HLA class II alleles and chronic hepatitis C virus infection.Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection.Immunopathogenesis of Hepatitis C Virus Infection.
P2860
Q27010312-5B30D6A6-875D-415B-9FC8-86EA8EBBF96CQ27488372-E145E5D5-CBB3-4883-8116-E393CD6CBAA7Q28678706-84930B0C-5906-4B19-917A-F0FB383102D7Q30392599-EB379A33-5DCA-4B48-BBEF-F6751C1FE4D8Q33796039-DB4B53CD-9469-4B97-825E-7FE290F13048Q33907429-C4FEA2F5-050C-4B4F-AD5A-F103F9967662Q34101320-E53A91A7-853D-48AA-806A-37358D14A888Q34158520-47331F2D-C37B-45D7-B529-97A670F1A322Q34168504-7ADF4883-E6E8-4D6E-B8BD-0C0D0AEB23DFQ35011376-2CC636D9-9A71-4D0A-BBC1-E48D790BB3D1Q35137038-117DE171-7829-4B09-8171-207AF2E75B0BQ35259735-3E91E9C5-1118-45F2-BFA3-904C0728B786Q36032616-4A4FE89C-F028-4806-8F0F-19C63E078ECEQ36287590-4E0E8304-A50C-4E6D-A741-292DD8CB5B27Q36729026-DFC3B8D6-91D8-4023-A4EF-6A07D3DD3594Q37046078-6C5E445F-437B-4187-AA0C-D2A635C7E98EQ37862746-B516ECD1-332F-4A0D-AC1D-4422A64851FDQ38088855-0F37586E-CFE6-4F8A-920E-9632CA08D06BQ38376339-68B2CDF1-27BB-469C-A45D-2CB7891387BBQ38741459-9A1D6186-9800-4BBB-9C38-5EA93935383CQ40171653-2ABBD0FD-7A0E-4520-8776-A3DB1C1395ABQ40943814-F60A65B6-17B7-49C2-A440-3CC5925BEF42Q41493589-AEA3A40C-7035-4663-829F-18EDE5C063C3Q42977154-A23A8183-342D-4C31-A8A3-2EBAA87B1228Q42985791-A50A1E20-9C98-498A-A23A-5709B3FCC5C3Q45324431-EEDE4413-CC8F-4BBD-A697-D76D34E595E7Q45347684-A27CFC96-8F41-404F-87D0-16FA17413E5AQ45356172-11AED64D-1CA4-4AC9-8C72-F42AAEE1CBFCQ45357502-AFE3A649-1A8D-4F7A-A175-D794C16B5D62Q45366916-3983FBE4-873B-4278-BD08-95721FD38745Q45389812-F573D82D-480E-4E68-9BC0-278C6C315ABDQ50934385-B4B8A865-B13D-4832-918B-7F4BB2E5FFD9
P2860
Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Human leukocyte antigen class ...... ucasians and African Americans
@ast
Human leukocyte antigen class ...... ucasians and African Americans
@en
Human leukocyte antigen class ...... ucasians and African Americans
@nl
type
label
Human leukocyte antigen class ...... ucasians and African Americans
@ast
Human leukocyte antigen class ...... ucasians and African Americans
@en
Human leukocyte antigen class ...... ucasians and African Americans
@nl
prefLabel
Human leukocyte antigen class ...... ucasians and African Americans
@ast
Human leukocyte antigen class ...... ucasians and African Americans
@en
Human leukocyte antigen class ...... ucasians and African Americans
@nl
P2093
P2860
P356
P1433
P1476
Human leukocyte antigen class ...... ucasians and African Americans
@en
P2093
Fusao Ikeda
Kazushi Sugimoto
Kyong-Mi Chang
Malek Kamoun
Rebecca A Harris
P2860
P356
10.1002/HEP.22287
P407
P577
2008-07-01T00:00:00Z